Inovio, Advaccine receive regulatory nod for two heterologous prime-boost trials in China using Covid-19 DNA vaccine.
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer...
|